NOVYRA PHARMACHEM LIMITED Share Price

NOVYRA PHARMACHEM LIMITED Share Price

BSE: 519353
|
Tea/Coffee
|
S Cap
₹ 9.16
+0.00 (0.00%)
1D
Last updated 22 Sep, 2026, 13:07 IST
--
0.00% up today
--
1D LOW
1D HIGH

NOVYRA PHARMACHEM LIMITED Returns Calculator

Circuit
L
H
₹8.71
₹9.61
52-week
L
H
₹5.88
₹16.55

About NOVYRA PHARMACHEM LIMITED

NOVYRA PHARMACHEM LIMITED Share Price
ISIN
INE856E01019
Sector Market Cap
₹ 5.80 Cr

Bansisons Tea Industries Limited is an India-based company. The Company is engaged in tea plantation, production and marketing.

NOVYRA PHARMACHEM LIMITED Financial Highlights

  • Revenue: NOVYRA PHARMACHEM LIMITED reported revenue of ₹0.16 crore in FY26 vs ₹0.05 crore in FY25. It showed an increase of 220.00% on a yearly basis.
  • Operating Profit: NOVYRA PHARMACHEM LIMITED reported an operating loss of ₹5.37 crore in FY26 vs ₹0.06 crore in FY25. It showed a decrease of 8,850.00% on a year-on-year basis.
  • Net Profit: NOVYRA PHARMACHEM LIMITED reported a net loss of ₹5.37 crore in FY26 vs ₹0.06 crore in FY25. It showed a decrease of 8,850.00% on a yearly basis.

NOVYRA PHARMACHEM LIMITED Quarterly Result Highlights

  • NOVYRA PHARMACHEM LIMITED reported revenue of ₹1.73 crore in Jun 2026, compared with ₹0.10 crore in Mar 2026, representing an increase of 1,630.00% on a quarter-on-quarter (QoQ) basis.
  • NOVYRA PHARMACHEM LIMITED reported an operating loss of ₹0.02 crore in Jun 2026, compared with ₹5.34 crore in Mar 2026, representing an increase of 99.63% on a quarter-on-quarter (QoQ) basis.
  • NOVYRA PHARMACHEM LIMITED reported a loss of ₹0.02 crore in Jun 2026, compared with ₹5.34 crore in Mar 2026, reflecting an increase of 99.63% on a QoQ basis.
  • The earnings per share (EPS) of NOVYRA PHARMACHEM LIMITED stood at ₹8.49 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Know more
Promoters
23.15%
FII
0.00%
Other DII
0.00%
Retail and other
76.85%
Mutual funds
0.00%
Foreign Institutional Investor (FII)
FII shareholding by period
Sep 20250.00%
Dec 20250.00%
Mar 20260.00%
Jun 20260.00%
Mkt Cap Cr
5.80
P/E
-1.08
P/B
9.32
ROE
-907.58%
D/E
0.00
ROCE
-907.58%
Div. Yield
0.00%
EPS(TTM)
-8.49
Turnover
1.25
EV/EBITDA
-1.11
Net Margin
-5,370.00%
Op. Margin
-5,340.00%
ROA
-368.49%
Quick Ratio
0.86
Curr. Ratio
0.83
Based on fundamentals, this stock's
Step 1 of 5
Performance
Very Poor
NOVYRA PHARMACHEM has not beaten FD return of 7%
Step 1 of 5
Valuation
Overvalued
NOVYRA PHARMACHEM appears overvalued compared to its peers
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
CCL Products14,009.1032.395.9816.55%0.4516.07%103.130.55%0.8821.56
Pix Transmissions2,360.6517.913.3915.34%0.0420.41%466.630.52%0.7267.58
TINNA RUBBER AND INFR LTD1,819.5929.516.0617.59%0.4419.28%162.700.32%1.0829.90
GRP1,066.67188.155.982.12%1.046.28%361.270.17%1.3016.74
McLeod Russel India469.74-5.03-1.08-43.86%-10.29-4.42%-34.430.00%0.49-8.70
International Conveyors494.943.641.1716.11%0.1819.40%66.430.64%0.3710.72
RUBFILA INTERNATIONAL LTD361.9614.071.148.13%0.0011.39%54.673.00%1.445.01
GAYATRI RUBB AND CHEM LTD327.0738.9111.0433.06%0.2837.73%11.040.00%2.069.74
Harrison Malayalam327.5712.091.8316.31%0.6214.42%96.800.00%1.0915.80
Elgi Rubber Co.299.45-1.513.96-113.56%0.98-13.93%38.880.00%0.58-22.97

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

NOVYRA PHARMACHEM LIMITED Financials

Full statement

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹0.10₹0.00₹0.00₹0.15
Other Income₹0.06₹0.05₹0.00₹0.01
Total Revenue₹0.17₹0.05₹0.00₹0.16
Total Expenses₹5.54₹0.11₹0.16₹0.12
Profit Before Tax-₹5.37-₹0.06-₹0.16₹0.03
Tax₹0.00₹0.00₹0.00₹0.02
Profit After Tax-₹5.37-₹0.06-₹0.16₹0.01
EPS - Basic-₹8.49-₹0.10-₹0.26₹0.02
EPS - Diluted-₹8.49-₹0.10-₹0.26₹0.02

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax-₹5.37-₹0.06-₹0.16₹0.03
Income before WC changes-₹5.41-₹0.08-₹0.14₹0.05
Change in Assets₹0.78₹0.06-₹0.03₹0.10
Change in Liabilities₹0.84-₹0.27₹0.04₹0.02
Change in WC₹1.62-₹0.21₹0.00₹0.11
Cash flow from Operations-₹3.79-₹0.28-₹0.14₹0.14
Cash flow from Investing₹3.85₹0.08₹0.00₹0.01
Cash flow from Financing-₹0.15₹0.28₹0.00₹0.00
Total Cash Flow-₹0.09₹0.08-₹0.14₹0.14
Cash (Start of the year)₹0.26₹0.09₹0.22₹0.08
Cash (End of the year)₹0.18₹0.26₹0.09₹0.22

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹0.74₹5.85₹5.89₹5.87
Current Assets₹0.75₹0.30₹0.23₹0.37
Total Assets₹1.49₹6.14₹6.12₹6.24
Current Liabilities₹0.87₹0.18₹0.09₹0.06
Net Current Asset-₹0.12₹0.12₹0.14₹0.31
Non-Current Liabilities₹0.00₹0.00₹0.10₹0.10
Equity Capital₹0.62₹5.97₹5.93₹6.09
Total Equity & Liabilities₹1.49₹6.14₹6.12₹6.24
* All values are in INR Crore
Qty
Bid
0
0
0
0
0
0
0
0
0
0
Ask
Qty
0
0
0
0
0
0
0
0
0
0
Bid Total: 0
Ask Total: 0
Buy orders: 0%
Sell orders: 0%
Bearish
2
Neutral
2
Bullish
4
Slightly Bullish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
47.71
Neutral
ATR (14)
0.31
Neutral
STOCH(9,6)
0
Bullish
STOCH RSI (14)
0
Bullish
ADX(9)
56.45
Bearish
UO(9)
24.58
Bullish
ROC(12)
-19.22
Bearish
WillR(14)
-100
Bullish
Period
Simple value
Exponential vaue
5D
10.06
9.84
10D
10.27
10.26
20D
10.94
11.03
50D
13.24
11.27
100D
12.15
0
Volume trend — traded volume by day
22 Sep0L
18 Sep0L
Average0L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks
NOVYRA PHARMACHEM LIMITED Share Price
NOVYRA PHARMACHEM LIMITED
Tea/Coffee
Add Stock
Add Another

NOVYRA PHARMACHEM LIMITED Share Price FAQs

NOVYRA PHARMACHEM LIMITED share price data is sourced from NSE/BSE and may be delayed. It is displayed for informational purposes only and does not constitute investment advice or a recommendation to buy or sell.

Trusted by 2 Crore+ Indians for their wealth-building needs. SEBI Registered Broker. SEBI Reg No. INZ000315837